Topper Copies

You are the Director of the National Bioethics Commission who is responsible for assessing the ethical feasibility and oversight of a nationwide gene sequencing program. The project named GeneFuture, aims to sequence the DNA of every newborn child and store it in a centralized national database. The objective is to identify genetic predispositions to serious diseases early in life, allowing for preventive treatment and personalized medicine. Over 100,000 babies have already been enrolled in the pilot phase of the program. The government claims that this move is a landmark step in public health advancement. However, collection of newborn genetic data raises significant ethical concerns, particularly around informed consent, which may not fully capture parents' understanding of the long-term risks involved. Once gathered, this sensitive data could be misused for purposes such as surveillance, insurance discrimination, or commercial marketing by third parties. Uncertainty over data ownership—whether it lies with the state, parents, or the individual as they mature—further complicates the issue. The involvement of private tech and pharmaceutical companies heightens fears of commercial exploitation, especially in the absence of clear mechanisms for individuals to withdraw consent or delete their genetic information upon reaching adulthood. (a) What are the ethical issues you perceive in the implementation of the GeneFuture program? (b) Identify the conflicting interests of different stakeholders in this case. (c) What guiding ethical principles would you recommend for implementation of this project?

Zinnia Aurora, AIR 6, 2025

Given case study reflects upon medical and digital/data ethics interface, and government's regulatory role.

(a) Ethical issues

1. Pursuit of teleological ends only -> consent of child not availed 2. Lack of 'informed decision making' - defective procedural justice and fairness 3. Corporatism and singular profiteering at cost of child 4. Lack of availability of mechanisms for redressal -> denial of justice 5. Big-Brother / Orwellian state qualities - informational withholding

(b) Conflicting interests

| Interest A | vs | Interest B | |---|---|---| | Government's medical prowess | vs | Child's genetic rights (recognised by SC) | | Collective good | vs | Individual good | | Public health | vs | Consent holisticity | | Corporates' profiteericity | vs | Dignity of genetic information | | Commercialised medical advancement | vs | Means, not an end |

(c) Ethical principles

'Primus non nocere' - First, hurt no one

1. Creation of ethical SOP for informed consent structure 2. Creation of data privacy flows -> individual/citizen centricity 3. Encryption of data or anonymisation -> aids medical health progress as well 4. Using child as 'means' - be regulated? - ensuring future recourse to grievance redressal

Thus, Gene Future must be kept avid in public health enforcement for larger achievement of 'right to health' (Article 21) but with due procedural mandates.